Zobrazeno 1 - 10
of 382
pro vyhledávání: '"Graciela M. Nogueras"'
Autor:
Wenli Liu MD, Baisong Zhong MD, Richard W. Wagner PhD, M. Kay Garcia DrPH, LAc, Jennifer L. McQuade MD, LAc, Wen Huang MD, PhD, Yisheng Li PhD, Graciela M. Nogueras Gonzalez PhD, Michael R. Spano MS, LAc, Alessandro Cohen MSc, Yimin Geng MS, MSLIS, Lorenzo Cohen PhD
Publikováno v:
Integrative Cancer Therapies, Vol 23 (2024)
Introduction: Inflammation is associated with tumor initiation, and existing tumors are associated with immune suppression locally and systemically. Cancer treatment is also associated with immune suppression. This review evaluates evidence related t
Externí odkaz:
https://doaj.org/article/857fef9fefdc4456945bba414831edc7
Autor:
Akanksha Srivastava, Graciela M. Nogueras-Gonzalez, Yimin Geng, Jasdev Singh, Jeffrey N. Myers, Yisheng Li, Mark S. Chambers
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 7, Iss 1, Pp 24-40 (2024)
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment; however, their oral toxicity profile is not well elucidated. This review aimed to investigate the prevalence of oral toxicities including xerostomia, mucositis/stomatitis, dysg
Externí odkaz:
https://doaj.org/article/3bbcadf3ffa54ca3a52f5788272ffd2c
Autor:
Wei Shen Tan, Valentina Grajales, Roberto Contieri, Patrick Hensley, Kelly Bree, Pavlos Msaouel, Charles C. Guo, Graciela M. Nogueras-Gonzalez, Neema Navai, Colin P. Dinney, Ashish M. Kamat
Publikováno v:
European Urology Open Science, Vol 53, Iss , Pp 16-22 (2023)
Background: Data for bladder-sparing treatment (BST) in bacillus Calmette-Guerin (BCG)-unresponsive non–muscle-invasive bladder cancer (NMIBC) patients report short-term outcomes limited to 1–2 yr. Objective: To assess long-term survival outcomes
Externí odkaz:
https://doaj.org/article/bc22d6eb975b4372ba604d04c4bfd745
Autor:
Henry Hiep Vo, Siqing Fu, David S. Hong, Daniel D. Karp, Sarina Piha-Paul, Vivek Subbiah, Filip Janku, Aung Naing, Timothy A. Yap, Jordi Rodon, Jaffer A. Ajani, Carrie Cartwright, Amber Johnson, I-Wen Song, Jennifer Beck, Michael Kahle, Graciela M. Nogueras-Gonzalez, Vincent Miller, Calvin Chao, David J. Vining, Donald A. Berry, Funda Meric-Bernstam, Apostolia-Maria Tsimberidou
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-12 (2022)
Abstract We investigated the challenges of conducting IMPACT2, an ongoing randomized study that evaluates molecular testing and targeted therapy (ClinicalTrials.gov: NCT02152254). Patients with metastatic cancer underwent tumor profiling and were ran
Externí odkaz:
https://doaj.org/article/0dcfdec9f8b24bf8a8a6b4c9cca14e08
Autor:
Akanksha Srivastava, Graciela M. Nogueras Gonzalez, Yimin Geng, Alexander M. Won, Jeffrey Myers, Yisheng Li, Mark S. Chambers
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 196-207 (2021)
Introduction: Medication-related osteonecrosis of the jaws (MRONJ) is a known adverse event related to the use of antiresorptive (AR) drugs. More recently, an association between antiangiogenic (AA) drugs and MRONJ has been suggested. This review aim
Externí odkaz:
https://doaj.org/article/ad0b919b514e48b586c4e41ed3716f1c
Autor:
Apostolia-Maria Tsimberidou, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Filip Janku, Aung Naing, Siqing Fu, Sarina Piha-Paul, Carrie Cartwright, Russell R. Broaddus, Graciela M. Nogueras Gonzalez, Patrick Hwu, Razelle Kurzrock
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-12 (2019)
Abstract Background In 2007, we initiated IMPACT, a precision medicine program for patients referred for participation in early-phase clinical trials. We assessed the correlation of factors, including genomically matched therapy, with overall surviva
Externí odkaz:
https://doaj.org/article/104ff192ed164bfea419fe086138f71a
Autor:
Ivo Veletic, Sanja Prijic, Taghi Manshouri, Graciela M. Nogueras-Gonzalez, Srdan Verstovsek, Zeev Estrov
Publikováno v:
Haematologica, Vol 106, Iss 9 (2020)
Phenotypic characterization of T cells in myelofibrosis (MF) is intriguing owing to increased inflammation, markedly elevated pro-inflammatory cytokines, and altered distribution of T-cell subsets. Constitutive activation of Janus kinase-2 (JAK2) in
Externí odkaz:
https://doaj.org/article/eb889aa1bd984a82a54b8e852552a188
Autor:
Naval Daver, Hagop Kantarjian, Guillermo Garcia-Manero, Elias Jabbour, Gautam Borthakur, Mark Brandt, Sherry Pierce, Kenneth Vaughan, Jing Ning, Graciela M. Nogueras González, Keyur Patel, Jeffery Jorgensen, Naveen Pemmaraju, Tapan Kadia, Marina Konopleva, Michael Andreeff, Courtney DiNardo, Jorge Cortes, Renee Ward, Adam Craig, Farhad Ravandi
Publikováno v:
Haematologica, Vol 102, Iss 10 (2017)
Vosaroxin is an anti-cancer quinolone-derived DNA topoisomerase II inhibitor. We investigated vosaroxin with decitabine in patients ≥60 years of age with newly diagnosed acute myeloid leukemia (n=58) or myelodysplastic syndrome (≥10% blasts) (n=7
Externí odkaz:
https://doaj.org/article/ec940b587bf2478fbb22e246c35b5afc
Autor:
Ozambela, Manuel, Jr, McCormick, Barrett Z., Rudzinski, Jan K., Pieretti, Alberto C., González, Graciela M. Nogueras, Meissner, Matthew A., Papadopoulos, John N., Adibi, Mehrad, Matin, Surena F., Dahmen, Aaron S., Spiess, Philippe E., Pettaway, Curtis A.
Publikováno v:
In Urologic Oncology: Seminars and Original Investigations April 2024 42(4):120-120
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.